Literature DB >> 3030699

Immunoreactive corticotropin-releasing factor in rat plasma.

T Sumitomo, T Suda, N Tomori, F Yajima, Y Nakagami, T Ushiyama, H Demura, K Shizume.   

Abstract

Immunoreactive ACTH (I-ACTH) levels in the rat anterior pituitary and plasma, and immunoreactive corticotropin-releasing factor (I-CRF) concentrations in the median eminence (ME) and plasma were determined after adrenalectomy and in insulin-induced hypoglycemia. I-CRF was detected in plasma from normal rats (mean +/- SD, 5.6 +/- 0.9 pg/ml; n = 6). Gel filtration chromatography of I-CRF from pooled plasma of these rats revealed a single peak which eluted in the position of authentic rat CRF. I-CRF levels in ME and I-ACTH levels in anterior pituitary decreased immediately after adrenalectomy, then gradually increased to high levels 14 days after surgery. Plasma I-CRF and I-ACTH concentrations increased immediately after surgery, slightly decreased to near the control levels at 24 h, and then increased to high concentrations 14 days after surgery. Plasma and ME I-CRF levels 14 days after adrenalectomy, followed by daily dexamethasone replacement, were almost the same as control levels. In insulin-induced hypoglycemia, plasma I-ACTH and I-CRF concentrations increased and ME I-CRF content decreased at 30 and 60 min. These results suggest that plasma I-CRF levels reflect changes in hypothalamic CRF levels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030699     DOI: 10.1210/endo-120-4-1391

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.

Authors:  M Schafer; S A Mousa; Q Zhang; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Lipopolysaccharide increases plasma levels of corticotropin-releasing hormone in rats.

Authors:  Miriam Goebel; Andreas Stengel; Lixin Wang; Joseph Reeve; Yvette Taché
Journal:  Neuroendocrinology       Date:  2010-12-06       Impact factor: 4.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.